⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAZZ News
Jazz Pharmaceuticals, Inc.
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL
Jazz Icon Wynton Marsalis Headlines Festival Napa Valley’s 20 th Anniversary Arts for All Gala, July 12, 2026
businesswire.com
JAZZ
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight
globenewswire.com
LULU
LIVN
AXSM
TAK
JAZZ
VNDA
LLY
AVDL
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight
globenewswire.com
LULU
LLY
AXSM
JAZZ
TAK
AVDL
RMD
VNDA
INSM
New Milestone Unlocked: Frontiers Online Becomes a Founding Member of the Haidian Technology Self-Media Committee and a Council Member of the Network Influencers Association, Officially Joining the Core Communication Ecosystem
prnewswire.com
JAZZ
SI
Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer
globenewswire.com
JAZZ
Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer
prnewswire.com
JAZZ
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX
ZIIHERA plus TEVIMBRA und Chemotherapie: Ein potenzieller neuer Standard für die Erstlinienbehandlung von HER2-positivem fortgeschrittenem GEA
businesswire.com
ONC
JAZZ
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit
prnewswire.com
JAZZ